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Abstract
Background:  Huntington's disease is a progressive autosomal dominant neurodegenerative
disorder that is caused by a CAG repeat expansion in the HD or Huntington's disease gene.
Although micro array studies on patient and animal tissue provide valuable information, the primary
effect of mutant huntingtin will inevitably be masked by secondary processes in advanced stages of
the disease. Thus, cell models are instrumental to study early, direct effects of mutant huntingtin.
mRNA changes were studied in an inducible PC12 model of Huntington's disease, before and after
aggregates became visible, to identify groups of genes that could play a role in the early pathology
of Huntington's disease.
Results:  Before aggregation, up-regulation of gene expression predominated, while after
aggregates became visible, down-regulation and up-regulation occurred to the same extent. After
aggregates became visible there was a down-regulation of dopamine biosynthesis genes
accompanied by down-regulation of dopamine levels in culture, indicating the utility of this model
to identify functionally relevant pathways. Furthermore, genes of the anti-oxidant Nrf2-ARE
pathway were up-regulated, possibly as a protective mechanism. In parallel, we discovered
alterations in genes which may result in increased oxidative stress and damage.
Conclusion: Up-regulation of gene expression may be more important in HD pathology than
previously appreciated. In addition, given the pathogenic impact of oxidative stress and
neuroinflammation, the Nrf2-ARE signaling pathway constitutes a new attractive therapeutic target
for HD.
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Background
Huntington's disease (HD) is a progressive autosomal
dominant neurodegenerative disease caused by a CAG
repeat expansion in the coding region of the HD gene,
resulting in an expansion of polyglutamines at the N-ter-
minus of the huntingtin protein and accumulation of the
mutant protein into cytoplasmic and nuclear aggregates
[1]. Larger expansions result in increased aggregation and
an earlier onset of pathological and clinical features [2].
The formation of aggregates is considered a hallmark of
HD [3,4]. The neuropathology of HD involves a selective
dysfunction and death of specific neuronal subpopula-
tions within the central nervous system [5].
Gene expression studies on animal model material and
low grade patient material have provided important infor-
mation on cellular processes and pathways involved in
HD pathology [6,7]. Not only is there a loss of normal
huntingtin function [8], upon expansion there is a toxic
gain of function resulting in a disruption of cellular func-
tions, including transcriptional deregulation, caspase acti-
vation and aberrant proteasomal processing [9]. In
addition, an increase in reactive oxygen species was
found.
Furthermore, the regional pattern of transcriptional
pathology in humans is in agreement with the pattern of
neurodegeneration [6]. The first detectable changes in
gene expression in mice carrying the first exon of mutant
huntingtin coincided with the first occurrence of patho-
logical and behavioural changes [10], again underscoring
the fact that gene expression is a good reflection of ongo-
ing changes towards pathology. Furthermore, transcrip-
tional changes, especially in the mouse models reflecting
more advanced stages of the disease, were similar to the
changes seen in human HD brain [7].
Although micro array studies on patient and animal tissue
provide valuable information, the primary effect of
mutant huntingtin will inevitably be masked by second-
ary processes in advanced stages of the disease. Thus, cell
models are instrumental to study early, direct effects of
mutant huntingtin, offering new insights into the patho-
genic mechanisms of HD. Especially studies of the early
stage are extremely important, because in this stage the
phenotype can still be reverted. A well established HD cell
model is the rat phaeochromocytoma (PC) 12 cell line,
which inducibly expresses exon 1 of the HD gene [11,12].
So far comprehensive expression profiling studies exploit-
ing data of the completed rat genome project were lack-
ing. The aim of this study was to find mRNA changes early
in the cellular pathology before and after the occurrence
of aggregates and to identify groups of genes that could
play a role in the pathology of HD.
Methods
Cell culture
Inducible rat PC12 cell lines expressing an exon 1 frag-
ment of huntingtin with 23 (Q23) or 74 (Q74) glutamine
repeats fused to the Green Fluorescent Protein (GFP),
[11,12] were cultured in standard high glucose Dulbecco's
modified Eagle's medium (DMEM, Invitrogen Life Tech-
nologies, Carlsbad, USA) supplemented with 100 U/ml
penicillin/streptomycin (Invitrogen Life Technologies), 2
mM L-glutamine (Invitrogen Life Technologies), 10%
heat-inactivated horse serum (Invitrogen Life Technolo-
gies), 5% Tet-approved heat inactivated fetal bovine
serum (Clontech, Palo Alto, USA), 100 μg/ml G418 (Inv-
itrogen Life Technologies) and 75 μg/ml hygromycin
(Invitrogen Life Technologies) at 37°C and 10% CO2.
Cells were induced with 1 μg/ml doxycycline (dox, Clon-
tech) and harvested on day 0 (uninduced cells), 1 day
(when only a few cells expressing mutant huntingtin con-
tain aggregates) and 5 days (when nearly all cells express-
ing mutant huntingtin contain aggregates) [12]. The same
culture conditions were used for PC12 cells without a con-
struct, to eliminate the effect of doxycycline treatment on
gene expression.
Hybridization design
For each construct, we performed duplicate experiments
with 2 independent cell lines for each construct (biologi-
cal replicates). Furthermore, from each cell line, two sep-
arate RNA isolations were performed (technical
replicates). RNA was harvested prior to induction (day 0),
after 24 hours of induction (day 1) and after 5 days of
induction. RNA was isolated with the QIAGEN RNeasy
Mini Kit (QIAGEN, Hilden, Germany) with on-column
DNase treatment. First-strand and second-strand cDNA
synthesis from total RNA was performed and biotin-mod-
ified NTPs were incorporated into the in vitro transcribed
cRNA with the Illumina TotalPrep RNA Amplification Kit
(Ambion, Foster City, USA). This biotin modified cRNA
was hybridized to the Illumina RatRef-12 Expression
BeadChip array (Illumina Inc., San Diego, CA, USA) and
labelled with Streptavidin-Cy3.
Statistical analysis
The average expression value of all beads per probe with
no background correction was obtained from BeadStudio
3.1.7. Further data analysis was performed in 'R' version
2.4.1. [13]. Data were normalized with the VSN method
using the VSN package for 'R' [14]. To establish signifi-
cance of differential gene expression, we used the empiri-
cal Bayes moderated t-statistics implemented in LIMMA
package version 2.8.1. for 'R' [15] and contrasts between
Q23 and Q74 were calculated per time point. Results were
adjusted for multiple testing by the Benjamini-Hochberg
method. Only probes were considered where the ratio on
day 0 had a P-value of >0.05 and the ratio on day1 or dayBMC Molecular Biology 2008, 9:84 http://www.biomedcentral.com/1471-2199/9/84
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5 had a P-value of <0.05. Microarray data discussed in this
work have been deposited in NCBI's Gene Expression
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) and
are accessible through GEO series accession number
GSE10581.
Functional classification
Functional classification was performed with the web
based tool DAVID http://david.abcc.ncifcrf.gov[16]. This
objective tool uses the one-tail Fisher Exact Probability
Value for gene-enrichment analysis. Significant gene
ontology terms for the Biological Process (BP), Cellular
Component (CC) and Molecular Function (MF) ontolo-
gies were analysed. Transcripts that showed a significant
increased or decreased differential expression at 1 day and
5 days were analyzed separately against a background list
of all genes present on the platform. Only categories with
a P-value < 0.05 containing two or more genes were con-
sidered.
Quantitative RT-PCR
Isolated total RNA, as described above, was also used for
qRT-PCR. RNA was quantified spectrometrically and
integrity was checked with the Agilent 6000 Nano Assay
(Agilent, Santa Clara, USA). Reverse transcription of RNA
was performed with the Transcriptor First Strand cDNA
Synthesis Kit (Roche, Basel, Switzerland). First Strand
cDNA Synthesis was performed with 2 μg of total RNA
and 2 μl (600 pmol/μl) random hexamer primers.
The LightCycler 480 PCR and detection system (Roche)
was used for amplification and real-time quantification.
PCR reactions of each sample were performed in triplicate
in a final volume of 10 μl in a 384 well plate (for primer
sequences see Additional File 1). The PCR mixture con-
tained 2 μl of 50× diluted cDNA template, 2 μl of 5×
qPCR-&GO LC480 Green Mastermix (Roche) (with 12.5
mM MgCl2) and primers at a final concentration of 250
nM with the following conditions: initial denaturation at
95°C for 10 min, followed by 45 amplification cycles at
95°C for 10 s, 60°C for 30 s, and 72°C for 20 s and final
extension at 72°C for 5 min. After the amplification reac-
tion melting curve analysis was performed, starting at
60°C and increasing to 98°C with 5 acquisitions/°C. Rel-
ative mRNA levels were calculated with the efficiency-cor-
rected Ct method with β-actin and Ywhaz as reference
genes and mRNA levels on day 0 (uninduced cells) as cal-
ibrator [17].
Immunohistochemistry
Cells were fixed in 4% paraformaldehyde for 15 min and
permeabilized in 50% methanol and 1% H2O2 for 20
min. After three washes in PBS containing 0.2% Triton X-
100 (PBS-Triton), cells were incubated overnight at 4°C
with rabbit anti tyrosine hydroxylase (1:2000, Santa Cruz
Biotechnology Inc., USA) in PBS-Triton with 1% normal
goat serum and 0.4% Thimerosal (Sigma, St. Louis, USA).
Cells were subsequently incubated with rabbit anti Alexa
594 (Invitrogen Life Technologies) and examined on a
Leica TCS SL confocal microscope.
Western blotting
Whole cell extracts (25 μg per lane) were separated by
SDS-PAGE and transferred to a PVDF membrane (Roche).
Blots were labelled with rabbit anti Tyrosine Hydroxylase
1:2000 (sc-14007, Santa Cruz Biotechnology Inc., Santa
Cruz, USA) followed by goat anti rabbit IgG conjugated to
horseradish peroxidase (Santa Cruz) in a 1:10,000 dilu-
tion and visualized by ECL plus (Amersham, Bucking-
hamshire, United Kingdom). Blots were stripped by
incubating in stripping buffer (100 mM β-mercapto-etha-
nol, 2% SDS, 62.5 mM Tris-HCl pH 8.0) for 30 min at
55°C and subsequently labelled for rabbit anti actin anti-
body 1:600 (clone C4, ICN Biochemicals Inc., Costa
Mesa, USA) and goat anti rabbit IgG conjugated to horse-
radish peroxidase (Santa Cruz) to check that equal
amounts of protein were loaded.
High Performance Liquid Chromatography (HPLC)
Whole cell extracts were prepared as described in the
Western blotting paragraph for HPLC analysis. Extracts
from 2 independent cell lines for each construct were fro-
zen immediately at -20°C until further analysis.
Dopamine concentration was measured by HPLC tech-
nology with electron capture detection with a detection
limit of 0.01 nmol/L [18]. Dopamine concentrations are
represented as μmol dopamine per gram of protein
extract.
Results
On day 1 after doxycycline-mediated induction of the
expression constructs, when aggregates had just started to
form, there were 145 of the approximately 22,500 tran-
scripts with a significantly changed ratio between Q23
and Q74 (P < 0.05 after correction for multiple testing).
Of those, 97 showed an increased expression compared to
the expression level on day 0, and 48 showed a decreased
expression. After 5 days of induction, when there was
extensive aggregation of the Q74 but not the Q23 contain-
ing protein, there were 1233 transcripts differentially
expressed of which 573 transcripts were up and 660 were
down. Of the 145 differentially expressed transcripts at
day 1, there were 51 also differentially expressed at day 5,
while 8 could be expected by chance alone. The other 95
returned to control levels at day 5.
Cellular processes changed before formation of aggregates
We were particularly interested in the molecular pathways
changed in the early stages of HD. Therefore, we evaluated
which pathways were represented in the list of transcriptsBMC Molecular Biology 2008, 9:84 http://www.biomedcentral.com/1471-2199/9/84
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with differential expression at day 1. Since there were no
significant categories when GO-based functional classifi-
cation was performed, all significantly changed transcripts
at 1 day were grouped according to their function (see
Table 1). Out of the 97 up-regulated transcripts, 54 were
included in the analysis while the remaining 43 tran-
scripts were of unknown function. Out of the 48 down-
regulated transcripts, 39 were analyzed and there were 9
transcripts of unknown function. The largest functional
group consisted of up-regulated transcripts coding for ion
channels and receptors, with an over-representation of
olfactory receptors. The next two largest groups contained
transcriptional and chromatin remodelling related tran-
scripts that were both up- and down-regulated. Transcripts
involved in cytoskeletal organization and cellular matrix
were mostly down-regulated in the mutant cells and there
seemed to be early signs of oxidative stress and impair-
ment in vesicle trafficking.
Table 1: Functional grouping of genes that show a significant change in expression between mutant and wild-type cells (Q74-Q23) after 
1 day of induction
Genes up after 1 day of mutant huntingtin expression Genes down after 1 day of mutant huntingtin expression
Gene Accession # Gene Accession # Gene Accession # Gene Accession #
Apoptosis-related proteins Cell cycle and growth factors
Gstp1 XM_579338 Tnfaip8* XM_225940 Igf2 NM_031511 Cdc14a* XM_227618
Cell cycle and growth factors Smpd3 NM_053605
Tgfa NM_012671 Cell signalling
Cell signalling Arl6* XM_344009 Plxnb1* XM_236640
Flrt2* XM_234361 Rgs14 NM_053764 Calm1 XM_579543 Panx2 XM_579735
Rasl11b NM_001002830 GAP1(sim) XM_227132 Chromatin remodeling – transcription
Rgs2 NM_053453 Smad4 NM_019275 Cbx6* XM_576309
Chromatin remodeling – transcription Chc1l NM_199084 Ttf2* XM_215670
Hoxb13* XM_220905 Vax2 NM_022637 Prickle1 XM_235609 Dnajb6* XM_342607
LOC362865 XM_343194 LOC368057 XM_347220 Mdc1 XM_227971
Npas1* XM_238770 Dclre1b* XM_227537 Cytoskeleton – cellular matrix
Hoxb9* XM_220887 Epb4.1l4a* XM_226060 RGD1310323 NM_001008348
Cytoskeleton – cellular matrix Add3 NM_031552 Cilp* XM_236348
Mybph NM_031813 Plekhh1* XM_234332
Electron transport – mitochondrion Electron transport – mitochondrion
LOC293949 XM_215248 Dhrs4 NM_153315
Ion channels – receptors Ion channels – receptors
Ms4a8b* XM_342026 Olr677* NM_001001062 Boc* XM_340986 Ms4a11* XM_342028
Ccr7 NM_199489 Olr1340* XM_236174 LOC501049 XM_576464 Olfml2b* XM_222868
Trpv6 NM_053686 Olr1597* NM_001000911 Trpv2 NM_017207
Olr29* NM_001000691 Ttyh3* XM_221962 Oxidative stress
Olr552* NM_001001055 Il17rb* XM_224604 Prdx6 NM_053576
Olr1751* NM_001000492 RNA processing and ribosomal
Oxidative stress Mrps15 NM_001007653 Rps16 XM_341815
Blvra NM_053850 Indo NM_023973 Vesicle trafficking
RNA processing and ribosomal Sec24d* XM_227663 Sytl4 NM_080410
Ear11 NM_138902 Rps24 NM_031112 Other
Trim21* XM_219011 Ptrh1* XM_342416 Tekt2* XM_575908 LOC500847 XM_576239
Vesicle trafficking Chst1* XM_575178 Adhfe1* XM_342794
Eml1* XM_343109 Lypla2 NM_031342 Pigl NM_138901
Other LOC365544 XM_345087 Herpud1 NM_053523
LOC499985 XM_575339 Atad2* XM_235326 LOC367880 XM_579653
Smyd2 XM_213972 LOC498435 XM_573687
Tpbg NM_031807 Smpx NM_053395
C4.4a NM_021759 Mocs1* XM_236911
Abhd1 NM_001008520 Serpinf1 NM_177927
Ppic NM_001004215 Smp2a NM_012695
Aak1* XM_232172 Rhcg NM_183053
Prss8 NM_138836 Prlph NM_021580
LOC367332 XM_346086 Xylt1 XM_341912
Cyp4a10 NM_153307
* predictedBMC Molecular Biology 2008, 9:84 http://www.biomedcentral.com/1471-2199/9/84
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Cellular processes changed after formation of aggregates
Results of the GO-based functional classification of tran-
scripts with differential expression between Q23 and Q74
expressing cells 5 days after induction, are presented in
Table 2. Only functional categories that were significantly
overrepresented (P < 0.05; hypergeometric test) compared
to the full list of features present on the array are dis-
played. The most significant terms for the up-regulated
transcripts were in the Biological Process (BP) category:
negative regulation of dendrite morphogenesis and
fibroblast proliferation, for the Cellular Component (CC)
category: antioxidant activity and stress fiber, and for the
Molecular Function (MF) category: electron transport
activity and chemokine receptor binding. The most signif-
icant terms for the down-regulated transcripts were in the
BP category: regulation of heart contraction and isopre-
noid biosynthesis, for the CC category: endosome mem-
brane and actin cytoskeleton, and for the MF category:
double-stranded DNA binding and SH3/SH2 adaptor
activity. Apoptosis related transcripts were expressed at
higher levels in the Q74 cells, as were transcripts involved
in mitochondrial biogenesis and electron transporter
activity, and transcripts involved in antioxidant activity.
This indicates an increased mitochondrial activity and a
response to oxidative stress in our cell model that was
already suggested at day 1. Actin and cytoskeletal-related
transcripts were mostly decreased in expression in the
mutant cell line compared to the wild-type cell line and
there was a large transcription regulation component in
the down-regulated transcripts. Cholesterol metabolism
was also significant in the group of down-regulated tran-
scripts, which is a pathway that was found in earlier gene
expression studies in HD [19].
Besides these significantly changed GO terms, a closer
examination of the array data revealed 5 transcripts of the
TGF beta signalling pathway significantly down-regulated
after 5 days (see Table 3) with the TGF beta transducer
Smad4 already down-regulated after 1 day of mutant
huntingtin expression. Two out of the eight Smad proteins
involved in the TGF beta signalling pathway were down-
regulated as well as TGF beta1.
Dopamine biosynthesis critically affected
Further examination of the dopamine biosynthesis path-
way by qRT-PCR revealed 5 genes involved in the
dopamine biosynthesis expressed at lower levels in the
mutant cell line compared to the wild-type cells (see Fig-
ure 1A).
To analyze the effect of these mRNA changes on protein
level, the TH protein was examined by immunohisto-
chemistry on cultured cells revealing a diffuse cytoplasmic
localization in the cells expressing wild type and mutant
huntingtin but there was a marked decrease of TH fluores-
cence in mutant cells (see Figure 1B). This reduction in TH
was confirmed by Western blotting of cell lysates from
independent isolations and a representative result is
shown in Figure 1C. This decrease in TH resulted in a sig-
nificant decrease in dopamine levels after 5 days in the
cells expressing mutant huntingtin as measured by HPLC
(see Figure 1D).
Oxidative stress
Many oxidative stress-related transcripts were up-regu-
lated and several classic Nrf2 (NF-E2 related factor 2/
Nfe2l2) responsive transcripts and oxidative stress related
genes (see Table 3) were differentially expressed after
analysis of the gene expression array.
Nrf2-responsive genes have been identified in previous
studies in cultures of primary cortical astrocytes and pri-
mary neuronal cultures and were classified as genes
involved in the antioxidant and detoxification response,
transcription, growth, inflammation and signalling path-
ways [20-22]. Interestingly, most Nrf2-responsive tran-
scripts involved in detoxification and antioxidant/
reducing potential were increased in expression in the
present study, while Nrf2-responsive transcripts involved
in transcription, growth, inflammation and signalling
pathways were not changed or expressed at lower levels in
the mutant cells. Subsequently, Nrf2-responsive genes
involved in antioxidant/reducing potential as well as
some non-Nrf2 responsive genes involved in protection
against oxidative stress were further examined by qRT-
PCR analysis. This analysis included additional oxidative
stress related genes that were present on the microarray
but where the change in gene expression did not reach sta-
tistical significance. Increased Nrf2-responsive transcripts
that have a protective role in the metabolic detoxification
of reactive intermediates are shown in Figure 2A. Nrf2-
responsive genes that act as antioxidants and are reducing
agents that prevent oxidative reactions that were expressed
at higher levels in the mutant cell line are shown in Figure
2B. While most Nrf2-responsive genes were up-regulated,
Hmox1, Taldo1 and Prdx6 were down-regulated.
Other transcripts, not identified as Nrf2- target genes, but
important antioxidant enzymes involved in the protec-
tion against oxidative stress, that were also expressed at
higher levels in the mutant cell line are shown in Figure
2C. Finally, several transcripts involved with electron
transport activity were expressed at higher levels on the
array in the cells expressing mutant huntingtin (see Table
3).
Discussion
To identify groups of genes that could play a role in the
pathology of HD, we studied mRNA changes in an induc-
ible PC12 HD model before and after aggregates becameB
M
C
 
M
o
l
e
c
u
l
a
r
 
B
i
o
l
o
g
y
 
2
0
0
8
,
 
9
:
8
4
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
1
9
9
/
9
/
8
4
P
a
g
e
 
6
 
o
f
 
1
3
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 2: Functional classification analysis of genes changed significantly after 5 days of mutant huntingtin expression
Functional Classification with genes that showed an increased expression after 5 
days
Functional Classification with genes that showed a decreased expression after 5 days
Ontology Term # genes P value Ontology Term # genes P value
BP Negative regulation of 
dendrite 
morphogenesis
3 0,004904 BP Regulation of heart 
contraction
7 0,000823
Negative regulation of 
fibroblast proliferation
3 0,004904 Isoprenoid biosynthesis 4 0,003744
Cell adhesion 16 0,009781 Galactose metabolism 3 0,005365
Response to DNA damage 
stimulus
8 0,011782 Angiogenesis 9 0,007585
Positive regulation of 
caspase activity
4 0,014506 Response to stress 40 0,007784
Positive regulation of 
hydrolase activity
4 0,019419 Neg. regulation of 
transcription 
from RNA polII promoter
8 0,007866
Apoptotic nuclear changes 3 0,021186 Cell motility 18 0,008263
Mitochondrial membrane 
organization 
and biogenesis
3 0,021186 Pos. regulation of 
transcription 
from RNA polII promoter
10 0,010333
Metal ion homeostasis 8 0,021801 Actin cytoskeleton 
organization 
and biogenesis
10 0,011951
Carbohydrate biosynthesis 6 0,023170 Blood vessel 
morphogenesis
9 0,015755
Biopolymer metabolism 38 0,024409 Cholesterol metabolism 7 0,016064
Fibroblast proliferation 3 0,026721 Glucose catabolism 6 0,022220
Protein oligomerization 4 0,035235 Histogenesis and 
organogenesis
3 0,024619
CC Antioxidant activity 5 0,015651 Regulation of neuronal 
synaptic 
plasticity
4 0,029030
Stress fiber 3 0,017610 Somitogenesis 3 0,033500
Cytoplasmic membrane-
bound vesicle
10 0,019229 Synaptic transmission, 
dopaminergic
3 0,033500
Nuclear chromosome 4 0,030424 cAMP metabolism 4 0,039722
MF Electron transporter activity 11 0,001023 Neurotransmitter transport 6 0,046079
Chemokine receptor binding 6 0,001069 CC Endosome membrane 3 0,008890B
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Metalloendopeptidase 
inhibitor activity
3 0,007766 Actin cytoskeleton 9 0,033881
Selenium binding 4 0,008247 Cell projection 13 0,033985
Protease inhibitor activity 7 0,013043 Cytoplasmic membrane-
bound 
vesicle
12 0,038151
GTPase activity 8 0,013763 Mitochondrion 24 0,043218
Guanyl nucleotide binding 9 0,040251 Spindle 4 0,048198
Zinc ion binding 17 0,041022 MF Double-stranded DNA 
binding
7 0,001838
244 genes
included in
analysis
SH3/SH2 adaptor activity 5 0,004637
Oxidoreductase activity, 
acting 
on the CH-CH group of 
donors
6 0,004683
Cell cycle regulator 4 0,005046
Epidermal growth factor 
receptor binding
3 0,023409
Protein phosphorylated 
amino 
acid binding
3 0,023409
Actin binding 10 0,026446
Monoamine transporter 
activity
3 0,031878
SNAP receptor activity 3 0,031878
Carbohydrate kinase 
activity
4 0,031902
Transcriptional activator 
activity
11 0,045287
331 genes
included in
analysis
BP: Biological Process.
CC: Cellular Component.
MF: Molecular Function
Table 2: Functional classification analysis of genes changed significantly after 5 days of mutant huntingtin expression (Continued)BMC Molecular Biology 2008, 9:84 http://www.biomedcentral.com/1471-2199/9/84
Page 8 of 13
(page number not for citation purposes)
visible. GO term analysis revealed many similarities with
previous human and whole animal gene expression stud-
ies indicating that this model system is useful to study
pathological markers for HD [6,7,23,24]. This is the first
study to show the involvement of Nrf2-responsive genes
in the oxidative stress response in HD. Oxidative stress
related transcripts were altered in expression, suggesting a
protective response in cells expressing mutant huntingtin
at an early stage of cellular pathology. Furthermore, there
was a down-regulation of dopamine biosynthesis result-
ing in lower dopamine levels in culture. Our results fur-
ther demonstrate an early impairment of transcription,
the cytoskeleton, ion channels and receptors.
Since it is not feasible to study early mRNA changes in
humans and it is more difficult to detect mRNA changes
in early stage mouse models of HD compared to later
stages [10], cell models are important to study the early
pathological cellular events in HD. Although cell models
are a simplified representation of the disease, it is less
likely that pathological markers are masked by secondary
disease processes and heterogeneous cell populations.
Notably, in the present study, the majority of transcripts
that changed on day 1 showed an increase in expression,
which is in contrast with previous studies where it was
found that most transcripts were decreased in expression
at the early stages in a mouse model of HD [7,23,24]. After
5 days of mutant huntingtin expression, more transcripts
were significantly changed compared to 1 day, and the
ratio of transcripts that increased to transcripts that
decreased in expression was approximately 1:1, which is
in agreement with previous findings [7]. This suggests that
up-regulation of transcription may be more important in
early HD pathology than previously appreciated. The rel-
evance of studies on mRNA level for the identification of
changes in biological processes is demonstrated for the
dopamine biosynthesis pathway, for which we showed
that a decrease in mRNA levels leads to concomitant
changes in dopamine levels.
We found early signs of oxidative stress with a differential
expression of mitochondrial, electron transport and oxi-
Table 3: Oxidative stress related genes that show a significant change with microarray analysis after mutant huntingtin expression
Nrf2 responsive genes
Gene name Accession# Ratio day 0 Ratio day 1 Ratio day 5 P value day 0 P value day 1 P value day 5
Detoxification
Nqo1 NM_017000 0,153161338 0,09509419 0,9313329 0,833712475 0,927082425 0,000223519 ▲
Gsta4 XM_217195 -0,275666227 -0,314801025 0,413131618 0,253015701 0,120614239 0,006374434 ▲
Gstp2 NM_138974 0,382499361 0,418277366 1,459294326 0,30465786 0,189513652 2,28E-07 ▲
Antioxidant/reducing Potential
Gclc NM_012815 0,050889982 0,064489288 0,553224444 0,935159305 0,921933889 0,000668569 ▲
Txnrd1 NM_031614 0,043006071 0,068186563 0,416963683 0,920763898 0,85987218 0,000404461 ▲
Prdx6 NM_053576 -0,529339334 -0,578113241 -0,680873497 0,084587704 0,038158555 0,003140611 ▼
Taldo1 NM_031811 0,009418008 0,032634451 -0,237774271 0,986167462 0,947870016 0,026954523 ▼
Me1 NM_012600 -0,000528861 0,013155505 0,269261838 0,998825398 0,98787689 0,021535996 ▲
Gene name Accession# Ratio day 0 Ratio day 1 Ratio day 5 P value day 0 P value day 1 P value day 5
TGF beta signalling pathway
Bambi NM_139082 -0,039617538 -0,026338592 -0,864880442 0,977785277 0,990188964 0,00336128 ▼
Smad4 NM_019275 -0,203348936 -0,40795009 -0,373068895 0,356782837 0,006017924 0,003289649 ▼
Map3k1 NM_053887 -0,299368715 -0,358856734 -0,690663403 0,55056724 0,382654757 0,004166232 ▼
Tgfb1 NM_021578 -0,126020083 -0,168731098 -0,366913617 0,684930689 0,490885028 0,004166232 ▼
Madh7 (smad7) NM_030858 -0,264074403 -0,230874139 -0,588447764 0,720614387 0,784042896 0,049193592 ▼
Oxidative stress
Epas1 NM_023090 -0,270174359 -0,478814403 -1,093139357 0,688153639 0,259648489 0,000173015 ▼
Frd1 XM_574642 0,131200174 0,166324378 0,387371459 0,560092481 0,355116774 0,000497262 ▲
Mt3 NM_053968 0,415104171 0,340566391 1,552629091 0,456685437 0,588382185 4,64E-06 ▲
Gpx1 NM_030826 0,118639332 0,007736138 0,307368335 0,5834878 0,991968688 0,002399689 ▲
Electron transport activity
Nqo1 NM_017000 0,153161338 0,09509419 0,9313329 0,833712475 0,927082425 0,000223519 ▲
Cyb561 XM_221030 -0,028644328 -0,034319208 -0,617267222 0,977340962 0,978641469 0,003179802 ▼
Cxcl10 NM_139089 0,113398034 0,222659258 1,175083864 0,855674156 0,616446381 1,06E-06 ▲
Phgdh NM_031620 0,019449285 0,127790463 0,21275382 0,963270227 0,538281599 0,044674848 ▲
Akr1b4 NM_012498 0,211752133 0,205849841 0,441397541 0,661683708 0,680952818 0,037660927 ▲
▲: increased expression; ▼: decreased expression; underscore means P value<0.05BMC Molecular Biology 2008, 9:84 http://www.biomedcentral.com/1471-2199/9/84
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dative stress related transcripts. The oxidative stress-
response became more obvious after 5 days where tran-
scripts of the Nrf2-ARE pathway were expressed at higher
levels in the cells expressing mutant huntingtin. Genes
containing the antioxidant response element (ARE) can
be activated by Nrf2 in response to oxidative stress [25] in
what is called the antioxidant response pathway [26].
Although there has been extensive evidence for a role of
oxidative stress early in HD pathogenesis [27] and an age-
dependent induction of compensatory mechanisms in
response to oxidative stress has been found in the R6/2
mouse model of HD[28], this is the first study implicating
Nrf2-responsive genes. While the majority of Nrf2-
dependent transcripts increased in expression after the
induction of mutant huntingtin, there were two tran-
scripts that showed a validated decreased expression.
Thus, only a subset of Nrf2 responsive genes is altered,
possibly due to a different combination of transcription
factor binding sites [29].
Mitochondrial dysfunction possibly contributes to this
oxidative stress, since this is thought to lead to decreased
production of ATP and an increase in reactive oxygen spe-
cies (ROS), ultimately leading to cell damage and cell
death [30]. A defect in mitochondrial complexes as well as
an increase in oxidative damage products has been found
in previous studies [28,31,32] and is in agreement with
our findings of an increase in transcripts involved in elec-
tron transport activity and oxidative stress response in
cells expressing mutant huntingtin.
We also found that the DNA repair gene Transaldolase1,
which promotes DNA stability and repair [33], was
expressed at lower levels in mutant cells compared to
wild-type cells in the current study. This is in agreement
with increased DNA oxidative damage products that have
been found in post mortem HD brain tissue [34,35].
That activation of the Nrf2 pathway can ameliorate the
effects of oxidative stress was shown when induction of
Nrf2-mediated transcription could protect cells from
mitochondrial complex II inhibition [36] and defects in
complex II have been implicated in HD [34,37,38].
Indeed, a study using an in vitro model of PD showed that
activation of the Nrf2-ARE pathway protected against 6-
hydroxydopamine neurotoxicity [39].
Conclusion
Combined micro array studies thus provide ample evi-
dence for the induction of a protective oxidative stress
response in cells expressing mutant huntingtin in an early
stage of the pathology [27]. This response may ultimately
be insufficient to protect cells from oxidative damage,
contributing to the massive cell death seen in HD brains.
Oxidative stress is thought to play a role in the pathogen-
esis of several other neurodegenerative diseases [40] and
Nrf2 has been implicated in the pathology of Alzheimer's
and Parkinson's disease. Given the pathogenic impact of
oxidative stress and neuroinflammation, the Nrf2-ARE
signalling pathway is an attractive therapeutic target for
neurodegenerative diseases and warrants further studies.
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Down regulation of the dopamine biosynthesis pathway in the PC12 model of Huntington's disease Figure 1 (see previous page)
Down regulation of the dopamine biosynthesis pathway in the PC12 model of Huntington's disease. A: qRT-PCR 
was performed on samples from Q 23 and Q74 cells for 0, 1 and 5 days. All values are expressed as relative mRNA levels com-
pared to expression levels of uninduced cells. SPR: Sepiapterin reductase, GCH1: GTP cyclohydroxylase 1, TH: Tyrosine 
hydroxylase, DDC: Dopa decarboxylase, DBH: Dopamine β-hydroxylase. * Significant differences between the day 1 and 5 
days; * P < 0.05, **P < 0.005, ***P < 0.0005 student's t-test. Significant differences between Q23 on day 1 and Q74 on day 1; + 
P < 0.05, ++P < 0.005 student's t-test. B: Confocal microscopic images of Q23 and Q74 PC12 cells after 5 days of induction. 
Green represents huntingtin-GFP and red represents TH immunohistochemistry. In Q23 cells, both huntingtin and TH show a 
diffuse staining, while in Q74 cells, large aggregates are visible and a clear reduction of TH fluorescence. Scale bar = 25 μm. C: 
Western blot analysis on whole cell lysates of Q23 and Q74 cells with TH and β-actin as loading control. A clear reduction in 
TH level can be seen in the 5 day Q74 samples. D: HPLC measurements in whole cell lysates of Q23 and Q74 cells after 0, 1 
and 5 days of huntingtin expression show a significant reduction in dopamine levels in the 5 day Q74 samples. (* P < 0.05, stu-
dent's t-test).BMC Molecular Biology 2008, 9:84 http://www.biomedcentral.com/1471-2199/9/84
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Nrf2-responsive genes and oxidative stress related genes were examined by quantitative real-time PCR on samples from cells  expressing wild type (Q23) and mutant (Q74) huntingtin for 0, 1 and 5 days Figure 2 (see previous page)
Nrf2-responsive genes and oxidative stress related genes were examined by quantitative real-time PCR on 
samples from cells expressing wild type (Q23) and mutant (Q74) huntingtin for 0, 1 and 5 days. All values are 
expressed as relative mRNA levels compared to expression levels on day 0 (uninduced cells) with β-actin and Ywhaz as refer-
ence genes. A: Nrf2 and Nrf2-responisve genes involved in detoxification. NRF2: NF-E2 related factor 2, NQO1: NAD(P)H 
dehydrogenase quinone 1, GSTA4: glutathione S-transferase alpha 4, GSTP2: glutathione S-transferase pi2. B: Nrf2-responsive 
genes involved in antioxidant/reducing potential. CAT: catalase, GCLC: the catalytic subunit of glutamate-cysteine ligase, 
GCLM: the modifier subunit of glutamate-cysteine ligase, HMOX1: heme oxygenase 1, TALDO1: transaldolase 1, FTL1: ferritin 
light chain, Me1: malic enzyme 1. C: Non-Nrf2 responsive genes involved in protection against oxidative stress. GPX1: glutath-
ione peroxidase, SOD1: superoxide dismutase 1, SOD2: superoxide dismutase 2, MT3: metallothionein 3. * Represents signifi-
cant differences between the day 1 and day 5 time points (* P < 0.05, **P < 0.005, ***P < 0.0005 student's t-test). + Represents 
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